Host: The Japanese Society of Toxicology
People have suffered from emerging diseases such as COVID-19. Viruses change the targets from molecules to organ in the human body. Moreover, excessive human defense functioning makes it more difficult to understand the infectious mechanisms. For tackling this issue, ontology thinking is effective that helps us to explicate the intrinsic natures of entities. This presentation will describe the systematization of COVID-19 infectious process knowledge based on the ontological approach. Moreover, some use cases of ontologies for risk management in new COVID-19 drug development will be discussed.
